Oncotalks hematology videos and news

EHA 2019 Prof. Heinz Gisslinger, MD

Prof. Heinz Gisslinger, MD Medical University of Vienna, Vienna, Austria commenting on REAL-WORLD SAFETY DATA FROM A NONINTERVENTIONAL LONG-TERM POSTAUTHORIZATION SAFETY STUDY OF RUXOLITINIB IN MYELOFIBROSIS which was presented at EHA 2019 in Amsterdam

References: EHA Library. BARRACO F. Jun 14, 2019; 266478

Link to abstract: https://library.ehaweb.org/eha/2019/24th/266478/fiorenza.barraco.real-world.safety.data.from.a.noninterventional.long-term.html?f=listing%3D0%2Abrowseby%3D8%2Asortby%3D1%2Asearch%3DREAL-WORLD+SAFETY+DATA+FROM+A+NONINTERVENTIONAL+LONG-TERM+POSTAUTHORIZATION+SAFETY+STUDY+OF+RUXOLITINIB+IN+MYELOFIBROSIS

Related items

EHA 2019 Jeroen Janssen, MD, PhD

EHA 2019 Jeroen Janssen, MD, PhD

Jeroen Janssen MD, PhD from the Amsterdam UMC, Amsterdam, The Netherlands is commenting on the abstract COMBINATION THERAPY USING ASCIMINIB PLUS IMATINIB (IMA) IN PATIENTS (PTS) WITH CHRONIC MYELOID LEUKEMIA (CML) & COMBINATION OF ASCIMINIB PLUS NILOTINIB (NIL) OR DASATINIB (DAS) IN PATIENTS (PTS) WITH CHRONIC MYELOID LEUKEMIA Reference: EHA Library. Kew S. Jun 15, 2019; 267467Link to abstract: https://library.ehaweb.org/eha/2019/24th/267467/sam.kew.combination.of.asciminib.plus.nilotinib.28nil29.or.dasatinib.28das29.in.html?f=listing%3D0%2Abrowseby%3D8%2Asortby%3D1%2Asearch%3Dasciminib
EHA , Latvia , Lithuania , Estonia , Albania
00:05:04
EHA 2019 Chinmay Munje, MD, PhD

EHA 2019 Chinmay Munje, MD, PhD

Chinmay Munje, MD, PhD from the Paul O’Gorman Leukaemia Research Centre, Glasgow, UK is commenting on the publication "COMBINATION OF ASCIMINIB (ABL001) WITH ATP-COMPETITIVE TYROSINE KINASE INHIBITORS TARGETS EARLY CML PROGENITOR CELLS", which was presented at EHA 2019 in AmsterdamReference: EHA Library. BARRACO F. Jun 14, 2019; 266478https://library.ehaweb.org/eha/2019/24th/266478/fiorenza.barraco.real-world.safety.data.from.a.noninterventional.long-term.html?f=listing%3D0%2Abrowseby%3D8%2Asortby%3D1%2Asearch%3DREAL-WORLD+SAFETY+DATA+FROM+A+NONINTERVENTIONAL+LONG-TERM+POSTAUTHORIZATION+SAFETY+STUDY+OF+RUXOLITINIB+IN+MYELOFIBROSIS
EHA , Lithuania , Albania
00:04:34
EHA 2019 Wolfgang Willenbacher, MD, PhD

EHA 2019 Wolfgang Willenbacher, MD, PhD

Wolfgang Willenbacher, MD, PhD from the Wolfgang Willenbacher, MD, PhD is commenting on the abstract PATIENT PERCEPTIONS ON SPLENECTOMY OUTCOMES: RESULTS FROM THE ITP WORLD IMPACT SURVEY (I-WISH), which was presented at EHA 2019 in AmsterdamReference: EHA Library. Cooper N. Jun 14, 2019; 266513Link to abstract: https://library.ehaweb.org/eha/2019/24th/266513/nichola.cooper.patient.perceptions.on.splenectomy.outcomes.results.from.the.html?f=listing%3D0%2Abrowseby%3D8%2Asortby%3D1%2Asearch%3DPATIENT+PERCEPTIONS+ON+SPLENECTOMY+OUTCOMES%3A+RESULTS+FROM+THE+ITP+WORLD+IMPACT+SURVEY+%28I-WISH%29
EHA , Lithuania , Albania
00:04:30